• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

February 22, 2016

Could the Gut Microbiome Be the Link Between PPIs and Dementia?

Understanding the potential biological mechanism of PPIs' effect on memory and cognition could establish safe clinical guidelines for long-term prophylactic use.

Proton pump inhibitors (PPIs) are potent drugs capable of reducing gastric acid secretion by more than 90% of normal physiological levels, allowing for the treatment of peptic ulcers.1

Presently, PPIs are widely used worldwide because of their OTC availability, unparalleled efficacy, and relative safety.2 The latter 2 could be attributed to the drugs’ unique selective accumulation into the acidic canaliculus of the stomach parietal cells, where they undergo acid-mediated chemical activation into a highly reactive intermediate that reacts irreversibly with the gastric hydrogen potassium ATPase (also known as the proton pump of the stomach), resulting in complete disruption of the terminal step of acid production and secretion.3

Current clinical evidence suggests that long-term PPI use is associated with serious adverse events because it alters the stomach pH, which interferes with the absorption of key vitamins, minerals, nutrients, and other drugs.4 Recently, a study published in JAMA Neurology suggested that long-term use could also be associated with dementia, although it did not establish a causative relationship.5

Understanding the potential biological mechanism of PPIs’ effect on memory and cognition could establish safe clinical guidelines for long-term prophylactic use.

Despite the fact that several studies have shown PPIs can cross the blood-brain barrier,6 it is less plausible that the drugs’ effect on cognition results from a direct effect on the brain alone. Several studies have shown that long-term PPI use could significantly alter the gut microbiome, resulting in an increased rate of enteric infections.7

The human microbiome has lately been under intense investigation.8 For instance, the gut microbiome was recently implicated in influencing the central nervous system through secretion of psychoactive molecules involved in mood control as well as cognition and development of Alzheimer’s disease.9

Based on these research findings, the association between long-term PPI use and dementia could be related to alteration of the gut microbiome. Proving such a hypothesis would raise additional questions about the pathogenesis of PPI-associated dementia and the condition’s reversibility.

Clearly, more work needs to be done to understand the mechanism behind PPI-associated dementia and provide more effective patient counseling. In the meantime, pharmacists may caution against long-term prophylactic PPI use and advise patients to consider alternative prophylactic approaches for long-term control of acid secretion, such as other antacid classes in combination with lifestyle changes.

References

1. Bavishi C, Dupont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011 Dec;34(11-12):1269-1281. doi: 10.1111/j.1365-2036.2011.04874.x. Epub 2011 Oct 17.

2. Durand C, Willett KC, Desilets AR. Desilets. Proton pump inhibitor use in hospitalized patients: is overutilization becoming a problem? Clin Med Insights Gastroenterol. 2012 Oct 15;5:65-76. doi: 10.4137/CGast.S9588. eCollection 2012.

3. Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep. 2008 Dec;10(6): 528-534.

4. Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012 Jul;5(4):219-32. doi: 10.1177/1756283X12437358.

5. Gomm W, von Holt K, Thomé F, Broich K, Maier W, et al. Association of proton pump inhibitors with risk of dementia. JAMA Neurol. 2016 Feb 15. doi: 10.1001/jamaneurol.2015.4791. [Epub ahead of print]

6. Fallahzadeh MK, Borhani Haghighi A, Namazi MR. Proton pump inhibitors: predisposers to Alzheimer disease? J Clin Pharm Ther. 2010 Apr;35(2):125-6. doi: 10.1111/j.1365-2710.2009.01100.x.

7. Imhann F, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2015;0: 1-9. doi:10.1136/gutjnl-2015-310376.

8. Devkota S. Prescription drugs obscure microbiome analyses. Science. 2016 Jan 29;351(6272):452-3. doi: 10.1126/science.aaf1353.

9. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. gut microbes and the brain: paradigm shift in neuroscience. J Neurosci. 2014 Nov 12;34(46):15490-6. doi: 10.1523/JNEUROSCI.3299-14.2014.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
Advertisement
Abstract representation of cholesterol levels with colorful particles floating. This illustrates complexity of blood components and cholesterol
July 10th 2025

With Proper Adherence to Cholesterol-Lowering Drugs, Thousands of Cardiovascular Events Could Be Avoided

Luke Halpern, Assistant Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Hyperlipidemia or arteriosclerosis. Blocked artery concept and human blood vessel as a disease with cholesterol fat buildup clogging. Clogged arteries, Cholesterol plaque in the artery. 3D
July 9th 2025

Reassessing the Safety and Efficacy of Very Low LDL Cholesterol

Maria DelPizzo, Senior Clinical Pharmacist Orgesa Cepo, Senior Clinical Pharmacist
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Elderly woman hands putting missing white jigsaw puzzle piece down into the place as a human brain shape. Creative idea for memory loss, dementia, Alzheimer's disease and mental health concept -  - Image credit: Orawan | stock.adobe.com
Published: July 9th 2025 | Updated: July 9th 2025

Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease

Kennedy Ferruggia, Assistant Editor
McKesson ideaShare 2025 Set to Empower Pharmacy Professionals in Nashville
July 9th 2025

McKesson ideaShare 2025 Set to Empower Pharmacy Professionals in Nashville

Aislinn Antrim, Managing Editor
Related Content
Advertisement
Abstract representation of cholesterol levels with colorful particles floating. This illustrates complexity of blood components and cholesterol
July 10th 2025

With Proper Adherence to Cholesterol-Lowering Drugs, Thousands of Cardiovascular Events Could Be Avoided

Luke Halpern, Assistant Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Hyperlipidemia or arteriosclerosis. Blocked artery concept and human blood vessel as a disease with cholesterol fat buildup clogging. Clogged arteries, Cholesterol plaque in the artery. 3D
July 9th 2025

Reassessing the Safety and Efficacy of Very Low LDL Cholesterol

Maria DelPizzo, Senior Clinical Pharmacist Orgesa Cepo, Senior Clinical Pharmacist
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
Elderly woman hands putting missing white jigsaw puzzle piece down into the place as a human brain shape. Creative idea for memory loss, dementia, Alzheimer's disease and mental health concept -  - Image credit: Orawan | stock.adobe.com
Published: July 9th 2025 | Updated: July 9th 2025

Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease

Kennedy Ferruggia, Assistant Editor
McKesson ideaShare 2025 Set to Empower Pharmacy Professionals in Nashville
July 9th 2025

McKesson ideaShare 2025 Set to Empower Pharmacy Professionals in Nashville

Aislinn Antrim, Managing Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.